Anti-angina effect of amiodarone in therapy-resistant angina pectoris
Meyer, B.J.; Gschwend, S.; Marx, B.; Amann, F.W.
Schweizerische Medizinische Wochenschrift 122(3): 70-72
1992
ISSN/ISBN: 0036-7672 PMID: 1346342 Document Number: 395470
In a double-blind randomized trial 63 patients on the waiting list for coronary artery bypass grafting, with stable angina NYHA III and a positive stress test on triple (nitrates, beta- and calcium entry blockers) combination therapy, were studied for an additional antianginal effect of amiodarone over a period of 2 months. In the treatment group an increase in exercise duration and a decrease of the double product and of ST-depression were noted. Thus, amiodarone is an effective antianginal agent in patients with limiting angina pectoris on conventional triple therapy.